Evidence map›Paper›PMID 40056291›Full record

ArticleDrug safety2025

Might We Come Together on a Paradigm Shift to Manage ICSRs with a Decentralized Data Model?

Lucinda Smith, Michael Glaser, Dieter Kempf, Xaymara Roman, Charlotte Artlich, Mayur A Patel, Andrew Bate

Abstract read
In one paragraph

Article in Drug safety, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Lucinda SmithProduct Development Safety Risk Management, Roche Products Limited, 6 Falcon Way, Shire Park, Welwyn Garden City, Hertfordshire, AL7 1TW, UK.
Michael GlaserGlobal Safety, GlaxoSmithKline, Collegeville, PA, USA.
Dieter KempfProduct Development Safety Risk Management, Genentech, A Member of the Roche Group, 1 DNA Way, South San Francisco, CA, 94080, USA. dkempf@gene.com.ORCID http://orcid.org/0009-0006-2611-8826
Xaymara RomanGlobal Medical Safety, Pharmacovigilance, Astellas Pharma Inc, Northbrook, IL, USA.
Charlotte ArtlichChief Medical Office, Pharmaceuticals, Bayer AG, Leverkusen, Germany.
Mayur A PatelGlobal Patient Safety Department, AstraZeneca, 101 Orchard Ridge Drive, Gaithersburg, MD, 20878, USA.
Andrew BateGlobal Safety, GSK, 79 New Oxford Street, London, WC1A 1DG, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The current practice of managing and sharing individual case safety reports (ICSRs) across the patient safety ecosystem, established in the 1960s, has become burdened with ICSR duplication and replication and can result in a fragmented understanding of product safety profiles. For this article, we have defined duplication as multiple representations of the same case within the same database and replication as various representations of the same case across numerous databases. Evolving safety regulations and increasing case volumes signal a need for a new path forward that is sustainable and enhances public health. While there is no question that ICSRs are a crucial component of safety surveillance, stakeholders must evaluate their management to ensure they are fit for purpose in a modern ecosystem. This article aims to embark on that path by proposing a conceptual decentralized ICSR management model to facilitate multi-stakeholder collaboration around new working models to mitigate duplication and replication, allow ecosystem stakeholders to access the latest source of truth on demand, facilitate more meaningful safety analysis and interpretation, and ultimately enable a real-time learning healthcare system to improve patient safety and health outcomes. It describes the feasibility analysis results and subsequently conducted proof of concept (PoC) based on a decentralized system architecture supporting such a decentralized model. It outlines considerations, challenges, and opportunities compared with the current state related to case management and signal management processes.

Indexed as

Adverse Drug Reaction Reporting SystemsPatient SafetyDatabases, FactualHumans

Identifiers

PMID40056291
PMCPMC12259765

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.